- Trials with a EudraCT protocol (701)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (10)
701 result(s) found for: Stimulation.
Displaying page 1 of 36.
EudraCT Number: 2013-001616-30 | Sponsor Protocol Number: 000071 | Start Date*: 2013-09-17 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing a... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) ES (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003177-32 | Sponsor Protocol Number: IBMR31 | Start Date*: 2022-11-17 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: Continuous ovarian stimulation in DUOSTIM cycles. | ||
Medical condition: Patients with predictive indicators of low ovarian response and who undergo double ovarian stimulation (DUOSTIM). | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002979-17 | Sponsor Protocol Number: MANCOR | Start Date*: 2014-01-27 |
Sponsor Name:IVI Sevilla | ||
Full Title: Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders | ||
Medical condition: Low response to ovarian stimulation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2022-002678-10 | Sponsor Protocol Number: GF22002 | Start Date*: 2023-03-07 |
Sponsor Name:Ginefiv | ||
Full Title: Protocol with progestin-primed ovarian stimulation (PPOS) starting on day 5 versus protocol with progestin-primed ovarian stimulation (PPOS) in a conventional regimen from the start of the ovaria... | ||
Medical condition: Number of MII oocytes obtained in both groups | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014810-87 | Sponsor Protocol Number: CL2-NEURO-005 | Start Date*: 2010-07-22 |
Sponsor Name:INSTITUT DE RECHERCHES INTERNATIONALES SERVIER | ||
Full Title: Effect of Memantine 20 mg (Ebixa) and Donepezil 5 mg (Aricept) on motor cortex plasticity induced by paired associative stimulation using transcranial magnetic stimulation (TMS) in patients sufferi... | ||
Medical condition: - Patients suffering from Mild Cognitive Impairment (memory problems, objective memory disorder, absence of other cognitive disorders or repercussions on daily life, normal general cognitive functi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-001342-18 | Sponsor Protocol Number: IB-0319-001 | Start Date*: 2019-08-19 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: CONVENTIONAL STIMULATION IN FOLICULAR PHASE VS. STIMULATION IN LUTEA PHASE IN PATIENTS WITH SUBOPTIMA RESPONSE. RANDOMIZED CLINICAL TRIAL. SUBLUTEAL STUDY | ||
Medical condition: Suboptimal response of ovarian stimulation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003484-56 | Sponsor Protocol Number: BOLDOS-18 | Start Date*: 2019-12-26 | |||||||||||
Sponsor Name:Miguel Caballero Campo | |||||||||||||
Full Title: Efficacy of corifolitropin alfa in double ovarian stimulation compared with two conventional ovarian stimulation cycles for embryo accmulation in low responder patients. Multicenter randomized cont... | |||||||||||||
Medical condition: Infertility in patients requiring in vitro fertilization treatment with poor ovarian response profile, defined by Bologna Criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005762-28 | Sponsor Protocol Number: 1512-VLC-066-EB | Start Date*: 2016-04-06 |
Sponsor Name:IVI Valencia | ||
Full Title: Analysis of follicular steroid synthesis during controlled ovarian stimulation with recombinant FSH vs HMG in GnRH antagonist cycles | ||
Medical condition: Women undergoing ovarian stimulation for oocyte donation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005443-24 | Sponsor Protocol Number: Dex-PKPD/01 | Start Date*: 2013-03-05 |
Sponsor Name:UMCG | ||
Full Title: Development of a pharmacokinetic/pharmacodynamic model of dexmedetomidine, and the effect of repeated auditory stimulation on pharmacodynamics of dexmedetomidine | ||
Medical condition: To develop a PKPD dexmedetomidine model, and to assess the effect of continuous auditory stimulation on dexmedetomidine pharmacodynamics. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001343-44 | Sponsor Protocol Number: IB-0319-002 | Start Date*: 2019-05-21 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: Conventional ovarian stimulation vs. stimulation with single injection of Corifollitropin alfa in oocyte donors. Randomized clinical trial. Tail Studio | ||
Medical condition: Oocyte donation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001669-17 | Sponsor Protocol Number: 000004 | Start Date*: 2013-09-17 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stim... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) PL (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005687-97 | Sponsor Protocol Number: NoSIRS | Start Date*: 2013-06-20 |
Sponsor Name:Medtronic Inc. | ||
Full Title: Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a pilot study | ||
Medical condition: Possible future indications: inflammatory conditions in general | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004298-15 | Sponsor Protocol Number: 1601-ALC-002-MM | Start Date*: 2018-10-04 | |||||||||||
Sponsor Name:IVI Alicante | |||||||||||||
Full Title: A Phase III multicentre, randomized, unblinded clinical trial to test the effect of treatment with recombinant LH prior to controlled ovarian stimulation in poor ovarian responder women with an a... | |||||||||||||
Medical condition: ovarian stimulation in poor ovarian responders | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005404-29 | Sponsor Protocol Number: E2I60 | Start Date*: 2015-12-04 | ||||||||||||||||||||||||||
Sponsor Name:SANOFI PASTEUR SA | ||||||||||||||||||||||||||||
Full Title: Safety of the DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM®) Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China | ||||||||||||||||||||||||||||
Medical condition: Healthy volunteers: active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by Haemophilus influenzae type b (such as meningitis, septicaemia, cellu... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019591-67 | Sponsor Protocol Number: 1008032 | Start Date*: 2010-06-01 | |||||||||||
Sponsor Name:CHU de SAINT-ETIENNE | |||||||||||||
Full Title: Pain assessment during general anesthesia : DOLANS Study | |||||||||||||
Medical condition: perioperative analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002341-30 | Sponsor Protocol Number: 1705-VLC-030-JG | Start Date*: 2017-09-11 | |||||||||||
Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDAD (IVI) | |||||||||||||
Full Title: Usefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors to prevent premature luteinization | |||||||||||||
Medical condition: prevent premature luteinitation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-005005-12 | Sponsor Protocol Number: D2.D12.Bemfola | Start Date*: 2018-05-28 | ||||||||||||||||
Sponsor Name:UZ Brussel | ||||||||||||||||||
Full Title: Initiation of ovarian stimulation with recombinant-human FSH (Bemfola®) in the late follicular phase, a randomised controlled study. | ||||||||||||||||||
Medical condition: Subfertility Oocyte donation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003049-37 | Sponsor Protocol Number: CS-10459 | Start Date*: 2022-11-23 |
Sponsor Name:UZ Brussel | ||
Full Title: Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial | ||
Medical condition: Volutary women who wish to donate their oocytes | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000801-21 | Sponsor Protocol Number: 20130218 | Start Date*: 2014-08-26 |
Sponsor Name:Academic Medical Center | ||
Full Title: Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the STIM-trial | ||
Medical condition: Ovarian stimulation in women with breast cancer prior to chemotherapy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000633-36 | Sponsor Protocol Number: 000009 | Start Date*: 2011-08-09 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multinational, multicentre trial assessing the dose-response relationship of FE 999049 in controlled ovarian stimulation in women undergoi... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) BE (Completed) CZ (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.